Valuation: Omnicell, Inc.

Market Cap 1.96B 1.72B 1.61B 1.47B 2.76B 188B 2.83B 19.04B 7.45B 92.8B 7.35B 7.19B 321B P/E 2026 *
55.2x
P/E 2027 * 43.6x
Enterprise Value 1.96B 1.72B 1.61B 1.47B 2.76B 188B 2.83B 19.04B 7.45B 92.8B 7.35B 7.19B 321B EV / Sales 2026 *
1.57x
EV / Sales 2027 * 1.49x
Free-Float
76.27%
Yield 2026 *
-
Yield 2027 * -
1 day-5.46%
1 week+7.12%
Current month+5.42%
1 month+6.96%
3 months+1.55%
6 months-10.84%
Current year-3.38%
1 week 39.13
Extreme 39.1301
44.27
1 month 39.13
Extreme 39.1301
48.06
Current year 31.75
Extreme 31.75
55
1 year 28.9
Extreme 28.9
55
3 years 22.66
Extreme 22.66
66.65
5 years 22.66
Extreme 22.66
187.28
10 years 22.66
Extreme 22.66
187.28
Manager TitleAgeSince
Chief Executive Officer 68 01/10/2002
Director of Finance/CFO 56 15/09/2025
President 50 01/07/2026
Director TitleAgeSince
Chairman 68 01/09/1992
Director/Board Member 70 01/01/2013
Director/Board Member 70 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
15/7/26 Sell

Chief Executive Officer

-10,000 0.0220%
1/7/26 Free

Chairperson

12,309 0.0271%
1/6/26 Free

Director

4,603 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-5.64%+7.12%+47.80%-30.69% 1.96B
+2.91%+12.60%-27.65%+1.76% 32.68B
+0.49%-8.94%-48.84%+136.63% 11.89B
+1.51%+4.12%-23.25%+67.97% 5.54B
-1.91%+4.99% - - 2.21B
+1.48%-2.88% - - 1.68B
+1.07%-6.58%-38.44% - 1.01B
-2.38%+0.35%+31.67%+100.23% 871M
+0.89%+1.80%-41.75%-54.07% 769M
-0.79%-10.00%+436.17%+687.50% 655M
Average -0.24%-2.14%+41.96%+129.91% 5.93B
Weighted average by Cap. +1.53%+1.58%-23.06%+45.89%

Financials

2026 *2027 *
Net sales 1.25B 1.1B 1.02B 939M 1.76B 119B 1.8B 12.13B 4.74B 59.12B 4.68B 4.58B 204B 1.32B 1.16B 1.08B 990M 1.85B 126B 1.9B 12.79B 5B 62.34B 4.94B 4.83B 216B
Net income 35.72M 31.38M 29.29M 26.88M 50.33M 3.42B 51.57M 347M 136M 1.69B 134M 131M 5.85B 45.83M 40.27M 37.59M 34.5M 64.57M 4.39B 66.17M 446M 174M 2.17B 172M 168M 7.51B
Net Debt - -
Logo Omnicell, Inc.
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
Employees
3,525
Date Price Change Volume
30/07/26 US$41.59 -3.39% 645,435
28/07/26 US$43.05 +3.76% 753,773
27/07/26 US$41.49 +1.20% 838,423
24/07/26 US$41.00 +2.86% 567,479
23/07/26 US$39.86 -2.45% 729,974
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
43.05USD
Average target price
61.29USD
Spread / Average Target
+42.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OMCL Stock